...
Items | Hierarchy/Topic | EARLY VISIBILITY OF PROPOSED CONTENT CHANGES | Planned Release timing (*this is provisional only and is subject to change) |
---|---|---|---|
1. | Release Schedule | Proposal to Move the International Monthly Release Date to the First of Each Month After initial consultation with the community, SNOMED International are proposing to change the dates of the International Edition from the end of each month, to the first of each month. This would mean that in addition to all of the other months, the “January” release would move from 31st January to the 1st January, and the “July” release would move from 31st July to 1st July each year. Further details of this proposal are to follow, however if you have any concerns in the meantime please provide feedback to release@snomed.org as soon as possible. | Q3 2023 |
2. | Body Structure | Inactivation of 9258009|Gravid uterus structure (body structure)| This concept will be inactivated, content that is modeled with this concept will be remodeled with a site of 35039007|Uterine structure (body structure)| along with occurrence <<307159006|Pregnancy time period (qualifier value)|. The domain of 246454002 |Occurrence (attribute)| will be extended to include << 71388002 |Procedure (procedure)| to support these content changes. Content areas that will be updated include 386811000|Fetal procedure (procedure)| and 386637004|Obstetric procedure (procedure)|. | Q2/Q3 2023 International Release |
3. | Clinical Finding | Update Hierarchy 90708001 |Kidney disease (disorder)| As part of the Quality Initiative Project, work has commenced on 90708001 |Kidney disease (disorder)|. Work is being undertaken in stages and upcoming sub-hierarchies will be posted here as the work progresses:
| 2023 International Release and future releases |
4. | Clinical Finding | Update for Concepts Using 'Caused by' Clinical finding concepts containing "Caused by" in their FSN will be reviewed and will be updated (if applicable) according to the editorial guidelines related to causation here. The main focus of the review will be the following category of concepts:
Additional content update may become applicable while reviewing these concepts for example:
| Q3 2023 International Release |
5. | Clinical Finding | "Did not attend X" or "Attended X" Clinical Finding Concepts Around 30 "did not attend X" or "attended X" findings concepts, e.g., 390923003 |Did not attend cardiac clinic (finding)|, will be inactivated from the international release as they are administrative concepts. | July 2023 International Release |
6. | Clinical Finding | Measurement Findings The six false positive and false negative measurement findings, e.g., 274684006 |False-positive serological test for syphilis (finding)|, will be inactivated with reason of Nonconformance to editorial policy. | August 2023 International Release |
7. | Product | Drug Content Analysis Project (DCAP) - Addition of Anti-Infective Clinical Drug Concepts DCAP was launched in September 2022 to identify clinical drug concepts that are published in participating National Release Center extensions and that are eligible for promotion to the international release (supported by appropriate references to authoritative source material). Concepts that are already published in the Norwegian drug extension have been reviewed by multiple countries participating in the group and content eligible for promotion to the international release of SNOMED CT has been identified. Approximately 100 concepts will be promoted to the international release and corresponding concepts for Medicinal Product (MP) 'containing only', and Medicinal Product Form (MPF) 'containing only' imported from Norway if missing. MP 'containing' concepts will be created in the international release as required. | Q2 2023 International Release |
78. | Procedure | Dental "Fit X" concept updates Dental procedure concepts in the format "Fit X” e.g. 234856007 |Fit removable orthodontic retainer (procedure)| will be inactivated with reason “ambiguous". This change has been agreed by the Dentistry CRG and will affect approximately 50 concepts. This work is part of Content Tracker IHTSDO-122 | Q2/Q3 2023 International Release |
89. | Procedure | Remodel for Heart Valve Replacement Procedure Concepts Heart valve replacement concepts will be remodeled as a surgical replacement procedure. Distinction will be made between replacement of native valves and implanted prosthetic valves. Updates for concepts with a prosthetic valve will include both mechanical and biological valves. Surgical REMOVAL and REPLACEMENT may not occur at the same point in time so a surgical replacement procedure may not subsume under surgical REMOVAL. These surgical methods are at the same level within the hierarchy. | Q2/Q3 2023 International Release |
910. | Content Improvement | Updates to the Inactivation Reason and Historical Association for 'On Examination' and 'Complaining of' Inactive Content Many of the 'on examination' and 'complaining of' concepts were previously inactivated with the inactivation reason of |Moved elsewhere| with a historical association value |Extension Namespace 1000000|. This content will be updated with an inactivation reason of |Non-conformance to editorial policy| and a historical association of |Alternative| to a suitable international concept. | Q3 2023 International Release |
1011. | MRCM | Update to MRCM Extend the domain of 246454002 |Occurrence (attribute)| by including << 71388002 |Procedure (procedure)|. The following is the expected MRCM range after the change. 246454002 |Occurrence (attribute)| << 272379006 |Event (event)| OR << 404684003 |Clinical finding (finding)| OR << 71388002 |Procedure (procedure)| | Q2/Q3 2023 International Release |
1112. | Qualifier Value | Resolution of Dose Form Inconsistency for 421366001 | Tablet for conventional release oral suspension (dose form) The Preferred Term (PT) of 421366001 | Tablet for conventional release oral suspension (dose form) | will be updated from “tablet for oral suspension” to “dispersible oral tablet.” This is in line with EDQM (also national data sets) where a dispersible tablet is equivalent to a tablet for oral suspension. The PT of 37 clinical drugs (CDs) that currently have a mixture of names will be updated to all use “dispersible oral tablet”. Therefore, users will be able to search for and translate these CDs more effectively. | Q3 2023 International Release |
1213. | Observable Entity | Review of CRS Requests in “Awaiting agreement compliance” Status from SNOMED CT – LOINC Cooperation Project CRS requests in “Awaiting agreement compliance” status due to the previous cooperative agreement between SNOMED International and Regenstrief Institute, Inc. have been reviewed in light of the new cooperative agreement, the latest SNOMED CT Editorial Guide, and the latest CRS guidance documents. Concepts deemed in scope are being added. | Q1-Q3 2023 International Release |
...